Evidence map›Paper›PMID 23991749›Full record

ReviewBritish journal of pharmacology2014

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Katalin Módis, Eelke M Bos, Enrico Calzia, Harry van Goor, Ciro Coletta, Andreas Papapetropoulos, Mark R Hellmich, Peter Radermacher, Frédéric Bouillaud, Csaba Szabo

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03783091 (A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock), which is not on this map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03783091 phase2completednot on this mapstarted 2019, after this paper: background citation

A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock

TypeinterventionalSponsorMedical College of WisconsinRan2019 to 2023Enrolled20ConditionsSeptic ShockArmsHydroxocobalamin, Placebo
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 161 citations in OpenAlex.

  1. A Paradigm Shift of HCurrent issues in molecular biology · 2026
    Review
  2. Review
  3. Hydrogen Sulfide Signaling in Neurodegenerative Movement Disorders.Handbook of experimental pharmacology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Role of Bacteria-Derived Hydrogen Sulfide in Multiple Axes of Disease.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Cystathionine-The Journal of international medical research · 2024
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. HBiomolecules · 2022
    Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Katalin MódisDepartment of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.
Eelke M Bos
Enrico Calzia
Harry van Goor
Ciro Coletta
Andreas Papapetropoulos
Mark R Hellmich
Peter Radermacher
Frédéric Bouillaud
Csaba Szabo
The University of Texas Medical Branch at Galveston · USUniversity Hospital Ulm · DEInstitut Cochin · FRUniversity Medical Center Groningen · NLUniversity of Groningen · NL

Funding

Project 9: The role of androgen/corticosteroid in fat, muscle and glucose metabolism of burn victimsP50GM060338 · NIGMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI HERNDON, DAVID N. · 2000 to 2017
$24.2M
Regulation of cellular bioenergetics by hydrogen sulfideR01GM107846 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SZABO, CSABA · 2014 to 2017
$1.2M
NIGMS NIH HHS P50 GM060338NIGMS NIH HHS P50GM060338NIGMS NIH HHS R01 GM107846
6 · The paper itself

Abstract

Emerging work demonstrates the dual regulation of mitochondrial function by hydrogen sulfide (H2 S), including, at lower concentrations, a stimulatory effect as an electron donor, and, at higher concentrations, an inhibitory effect on cytochrome C oxidase. In the current article, we overview the pathophysiological and therapeutic aspects of these processes. During cellular hypoxia/acidosis, the inhibitory effect of H2 S on complex IV is enhanced, which may shift the balance of H2 S from protective to deleterious. Several pathophysiological conditions are associated with an overproduction of H2 S (e.g. sepsis), while in other disease states H2 S levels and H2 S bioavailability are reduced and its therapeutic replacement is warranted (e.g. diabetic vascular complications). Moreover, recent studies demonstrate that colorectal cancer cells up-regulate the H2 S-producing enzyme cystathionine β-synthase (CBS), and utilize its product, H2 S, as a metabolic fuel and tumour-cell survival factor; pharmacological CBS inhibition or genetic CBS silencing suppresses cancer cell bioenergetics and suppresses cell proliferation and cell chemotaxis. In the last chapter of the current article, we overview the field of H2 S-induced therapeutic 'suspended animation', a concept in which a temporary pharmacological reduction in cell metabolism is achieved, producing a decreased oxygen demand for the experimental therapy of critical illness and/or organ transplantation.

Indexed as

AnimalsDiabetes ComplicationsEnergy MetabolismGasotransmittersHibernationHumansHydrogen SulfideMitochondriaNeoplasmsShockGasotransmittersHydrogen Sulfide3-mercaptopyruvate sulfurtransferasebioenergeticsblood vesselscysteinefree radicalsgasotransmittersischaemiamitochondrial electron transportnitric oxideshocksuperoxidesuspended animation

Identifiers

PMID23991749
PMCPMC3976626
OpenAlexW1516260708

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.